More precisely, four members of the fibroblast growth factor receptor family (FGFR3, FGFR2, FGFR4 and FGFR1) and the Zeta-chain-associated protein kinase 70 (ZAP70) were more active in ET. The gene discussed is FGFR4; the disease is essential thrombocythemia.